What is the latest dengue treatment guidelines with warning signs to be followed in india
Reading File
Reading File
Finding Sources
Searching the Web
site:ncvbdc.mohfw.gov.in dengue case management guidelines India warning signs 2025 OR 2026
Searching PubMed
dengue warning signs management India
Reading Web Page
https://ncvbdc.mohfw.gov.in/Doc/National%20Guidelines%20for%…
Reading File
Finding Sources
India’s current detailed national clinical reference is the National Guidelines for Clinical Management of Dengue Fever (2023) from the Ministry of Health and Family Welfare / NCVBDC. The NCVBDC dengue case-management page was updated in November 2025, but I could not find a newer replacement for the 2023 clinical guideline.
Dengue has no specific antiviral treatment. Management is careful monitoring, appropriate fluids, paracetamol for fever, and urgent escalation when warning signs occur.
1. Home management: mild dengue, Group A
Appropriate only when the person is alert, drinking adequately, passing urine, has no warning signs or major comorbidity, and can return promptly for review.
- Fluids: frequent oral fluids, such as water, ORS, soups, coconut water, etc. Avoid overconsumption if a clinician has advised fluid restriction for heart or kidney disease.
- Fever/pain: use paracetamol only, as advised by a clinician.
- Avoid: aspirin, ibuprofen, diclofenac, naproxen and other NSAIDs because they can increase bleeding risk. Do not self-medicate with steroids or antibiotics.
- Monitor fever pattern, vomiting, abdominal pain, bleeding, urine output, alertness, and daily clinical review/CBC as advised.
- A falling fever does not always mean recovery. The higher-risk critical phase commonly begins around days 3-7, often as the fever settles, and lasts about 24-48 hours. Rising haematocrit with a rapidly falling platelet count can signal plasma leakage. Park’s Textbook of Preventive and Social Medicine, critical phase section.
2. Warning signs: go to hospital immediately
The national guideline advises admission and close observation for dengue with any warning sign:
- Severe abdominal pain or abdominal tenderness
- Persistent or repeated vomiting
- Clinical fluid accumulation, such as abdominal swelling/ascites or fluid around the lungs
- Mucosal bleeding: nose bleed, gum bleed, vomiting blood, black stools, heavy menstrual bleeding, blood in urine
- Lethargy, unusual drowsiness, irritability, or restlessness
- Liver enlargement or pain/fullness in the right upper abdomen
- Increasing haematocrit together with a rapid fall in platelets
Also seek emergency care for cold or clammy extremities, fainting, dizziness, fast weak pulse, reduced urine output, breathlessness, confusion, seizures, or a narrow pulse pressure. These can indicate poor circulation or progression to severe dengue.
3. Who should be assessed/admitted earlier, even without classic warning signs?
The Indian guideline advises a lower threshold for hospital observation for:
- Infants, older adults, and pregnant people
- People with diabetes, heart disease, hypertension, chronic liver or kidney disease, asthma/COPD, TB/HIV, coagulation disorders, or immunosuppression
- People taking anticoagulants, antiplatelets, NSAIDs, or immunosuppressive drugs
- Poor oral intake, dehydration, inability to return quickly to hospital, or unreliable home observation
4. Hospital treatment: dengue with warning signs, Group B
This requires clinical monitoring, including vital signs, mental status, urine output, fluid input-output charting, serial haematocrit, platelet trend, glucose, and renal/liver tests as indicated.
- If oral fluids are not tolerated or there is plasma leakage, clinicians use carefully titrated isotonic IV crystalloid fluids, typically 0.9% normal saline or Ringer’s lactate.
- Fluid treatment must be reassessed frequently. Too little fluid can worsen shock; too much can cause pulmonary edema/respiratory distress, especially as the leakage phase resolves.
- A haematocrit increase of 20% or more from baseline suggests substantial leakage and requires urgent medical management.
- Platelet count alone should not determine fluid therapy or discharge.
5. Severe dengue: Group C, emergency
Severe dengue includes any of the following:
- Shock from major plasma leakage, or fluid accumulation causing respiratory distress
- Severe bleeding
- Severe organ involvement: liver injury, kidney impairment, encephalopathy/encephalitis, myocarditis, or severe metabolic abnormalities
Treatment requires urgent hospital admission, stabilization, carefully managed IV resuscitation, oxygen when required, and blood-product support when there is clinically significant bleeding or shock from hemorrhage. The national guideline recommends crystalloid as the initial resuscitation fluid, with blood transfusion considered when the clinical and haematocrit pattern suggests significant bleeding.
Important point about platelets
A low platelet count is common in dengue, but platelet transfusion is not routinely given just because the number is low. Decisions depend mainly on active/significant bleeding, shock, planned invasive procedures, and overall clinical status. A person with low platelets but stable vital signs and no bleeding needs clinician-directed monitoring, not automatic platelet transfusion.
For the full Government of India algorithms, including clinician fluid-rate tables and admission/discharge criteria:
The NCVBDC management page confirms that dengue management is symptomatic and supportive. The 2023 national clinical guideline provides the Group A/B/C pathway and specifies that warning signs warrant hospital management.
Emergency message: if someone with suspected or confirmed dengue has any warning sign, especially persistent vomiting, severe abdominal pain, bleeding, reduced urine, breathlessness, fainting, cold clammy limbs, or altered behavior, they should go to an emergency department now rather than wait for the next platelet result.
Give me the treatment guidelines and investigations and what to check and how is each value changes and it's significance
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web
site:ncvbdc.mohfw.gov.in/Doc "National Guidelines for Clinical Management of Dengue Fever 2023" investigation CBC haematocrit fluid management
Searching PubMed
dengue clinical management laboratory monitoring
Below is a practical, patient-oriented summary of the Indian NCVBDC/MoHFW 2023 dengue clinical-management guideline. It is not a substitute for a treating clinician, especially during days 3-7 of illness, when a person can worsen rapidly even as fever comes down.
The official NCVBDC 2023 guideline classifies illness as:
- Group A: Mild dengue - outpatient management
- Group B: Dengue with warning signs or higher risk - hospital observation/admission
- Group C: Severe dengue - emergency stabilization and referral/admission
1. What to check at every assessment
Clinical checks
| What to assess | Concerning change | Why it matters |
|---|---|---|
| Day of illness and fever pattern | Fever settling around day 3-7 with new worsening symptoms | This may be the beginning of the critical phase, when plasma leakage can occur |
| General condition and mental state | Restlessness, lethargy, drowsiness, confusion | Can be an early sign of poor circulation, shock, hypoglycaemia, or organ involvement |
| Blood pressure and pulse pressure | Falling BP, weak rapid pulse, or pulse pressure <20 mmHg | Suggests compensated or decompensated shock |
| Peripheral perfusion | Cold clammy hands/feet, delayed capillary refill, weak pulse | Indicates reduced effective circulating volume |
| Urine output | Less than 0.5 mL/kg/hour or clearly reduced urine | Important early marker of poor kidney perfusion/shock |
| Respiratory status | Breathlessness, oxygen desaturation, lung crackles | May indicate pleural fluid from leakage, shock, or excessive IV fluid |
| Bleeding | Gum/nose bleed, vomiting blood, black stool, vaginal bleeding, blood in urine | May be mucosal or major internal bleeding |
| Abdominal symptoms | Severe pain/tenderness, persistent vomiting, liver enlargement | Warning signs of progression |
| Fluid balance | Fluid intake, vomiting, IV fluids, urine output, edema | Prevents both under-resuscitation and dangerous fluid overload |
At home: check ability to drink, vomiting, urine frequency, alertness, bleeding, abdominal pain, and breathing. Do not wait for a platelet report if warning signs develop.
2. Investigations and their significance
A. Tests to confirm dengue
| Test | Best timing | Interpretation |
|---|---|---|
| NS1 antigen | Usually early illness, especially first 5 days | A positive test supports acute dengue. A negative test does not always exclude dengue, particularly later in illness. |
| RT-PCR / NAAT | Early febrile phase, ideally in first week | Detects viral RNA and confirms acute infection. It is most useful early. |
| Dengue IgM MAC-ELISA | Usually from day 5 onward | Supports recent dengue infection. Testing too early can be falsely negative. |
| IgG | Mainly for epidemiology or evidence of past/secondary infection | IgG alone does not necessarily mean the current fever is due to dengue. |
Practical point: do not delay fluids or referral while waiting for NS1, PCR, or IgM results if the clinical picture suggests dengue with warning signs.
B. Baseline and serial monitoring tests
| Investigation | Typical change in dengue | Clinical significance |
|---|---|---|
| Haematocrit, Hct/PCV | May rise as plasma leaks out of blood vessels | A rising Hct, especially with falling platelets, suggests plasma leakage. A rise of about 20% above baseline is an important danger signal in the Indian guideline. |
| Platelet count | Often falls from day 3 onward; nadir often occurs around the critical phase | A falling trend supports dengue but the number alone does not predict bleeding reliably. A rapid fall with rising Hct is more concerning than a low count in isolation. |
| Total leukocyte count, TLC | Leukopenia is common | Helps support dengue but is not diagnostic alone. A rising white-cell count in a deteriorating patient can suggest bleeding, bacterial sepsis, or severe illness. |
| Haemoglobin, Hb | May rise with haemoconcentration; may fall with bleeding or after fluids | Rising Hb with rising Hct suggests concentration from leakage. A sudden Hct/Hb fall in an unstable patient raises concern for significant bleeding. |
| Peripheral smear / malaria test | Used to identify malaria or another cause of fever | Important in India because malaria and dengue may mimic one another and can coexist. |
| Blood glucose | May be low, especially in children, poor intake, severe illness, or altered sensorium | Hypoglycaemia must be corrected promptly. |
| Serum electrolytes | Sodium/potassium abnormalities may occur with vomiting, leakage, renal dysfunction, or IV fluids | Guides safe fluid and electrolyte correction. |
| Renal function: urea, creatinine | May rise in dehydration, shock, or acute kidney injury | Indicates organ involvement and helps tailor fluid therapy. |
| Liver tests: AST/ALT, bilirubin | AST/ALT may increase; major rise can occur in severe dengue | Assesses hepatic involvement. Severe hepatitis is a criterion for severe dengue. |
| Coagulation profile: PT/INR, aPTT, fibrinogen | Can be abnormal in severe bleeding, liver dysfunction, or DIC | Used when there is significant bleeding, shock, severe dengue, or planned invasive procedures. |
| ABG/VBG and lactate | Acidosis or elevated lactate in shock | Indicates inadequate tissue perfusion and severity. |
| Chest radiograph or ultrasound | Pleural effusion, ascites, gallbladder-wall edema | May demonstrate plasma leakage if clinically suspected. Use when it will alter management, not as a routine test for every uncomplicated case. |
3. How laboratory values change by phase
Febrile phase: usually days 1-3, sometimes up to day 7
Common pattern:
- High fever, headache, retro-orbital pain, myalgia, rash, nausea.
- WBC often falls.
- Platelets may be normal initially, then begin to fall.
- Hct is often near baseline.
- NS1/PCR is most useful early.
Meaning: focus on oral hydration, fever control with paracetamol, and daily reassessment. A normal platelet count early does not rule out later deterioration.
Critical phase: usually around defervescence, days 3-7, lasting about 24-48 hours
This is the phase needing the closest observation.
Typical pattern:
- Fever reduces, but the patient may become worse.
- Hct rises due to plasma leakage.
- Platelets drop rapidly.
- Urine output may decrease.
- Pleural effusion or ascites can develop.
- Warning signs and shock can appear.
High-risk pattern:
rising Hct + rapidly falling platelet count + clinical deterioration = probable plasma leakage until proven otherwise.
rising Hct + rapidly falling platelet count + clinical deterioration = probable plasma leakage until proven otherwise.
Recovery phase: approximately 48-72 hours after the critical phase
Typical pattern:
- Appetite and general condition improve.
- Urine output improves.
- Hct stabilizes or falls toward baseline as leaked fluid is reabsorbed.
- Platelets usually begin to rise, often later than clinical improvement.
- Diuresis may occur.
Important danger: if IV fluids are continued too aggressively during recovery, fluid overload and pulmonary edema can occur.
4. Warning signs that require hospital assessment/admission
Go to an emergency department urgently for any of the following:
- Severe abdominal pain or abdominal tenderness
- Persistent vomiting
- Mucosal bleeding: gums, nose, vomit, stool, urine, or heavy menstrual bleeding
- Fluid accumulation: abdominal swelling, breathing difficulty, pleural effusion
- Lethargy, unusual sleepiness, restlessness, confusion
- Liver enlargement or right-upper abdominal pain
- Rapid platelet fall together with rising Hct
- Cold clammy extremities, dizziness, fainting, fast weak pulse
- Narrow pulse pressure, low BP, reduced urine output
- Breathlessness, low oxygen saturation, seizures, or altered consciousness
The guideline also advises a lower threshold for admission in pregnancy, infancy, old age, diabetes, heart disease, kidney disease, chronic liver disease, bleeding disorders, immunosuppression, and use of anticoagulant or antiplatelet drugs.
5. Treatment guideline by severity
Group A: mild dengue, outpatient care
Suitable only if the patient has no warning signs, can drink, passes urine, is clinically stable, and has reliable follow-up.
Treatment
- Oral fluids in frequent small amounts.
- ORS can be used if vomiting/poor intake is mild.
- Paracetamol for fever and pain, within clinician-advised dosing.
- Tepid sponging if needed.
- Daily reassessment during the risk period, with CBC/Hct testing as advised.
Do not use
- Aspirin
- Ibuprofen
- Diclofenac
- Naproxen
- Other NSAIDs
- Steroids unless there is another clear medical indication prescribed by a clinician
- Unnecessary antibiotics
- Intramuscular injections where avoidable, because of bleeding risk
Group B: dengue with warning signs or significant risk factors
Requires hospital observation or admission.
Main treatment principle: careful isotonic fluid therapy
- Encourage oral fluids only if the person is not vomiting and is clinically stable.
- If oral intake is inadequate or warning signs are present, clinicians use isotonic IV crystalloid, usually 0.9% normal saline or Ringer’s lactate.
- Baseline Hct should be taken before fluids if immediately available, but fluid treatment must not be delayed in an unwell patient.
- Monitor pulse, BP, pulse pressure, respiratory rate, mental state, urine output, Hct, and fluid balance.
- Fluid rate is adjusted repeatedly according to clinical response and Hct trend, then reduced stepwise as perfusion improves.
Why Hct guides fluids
- High/rising Hct with poor perfusion: ongoing plasma leakage, so carefully titrated crystalloid may be needed.
- Falling Hct with persistent shock: consider major bleeding, especially if there are bleeding manifestations. This needs urgent senior assessment and may require blood transfusion.
- Improving perfusion with falling/stable Hct: fluids should generally be reduced to avoid overload.
Group C: severe dengue, emergency management
Severe dengue means:
- Shock due to plasma leakage
- Fluid accumulation causing respiratory distress
- Severe bleeding
- Severe liver, kidney, brain, heart, or metabolic involvement
Treatment
- Immediate stabilization and urgent admission to a facility capable of critical monitoring and blood transfusion.
- Judicious IV crystalloid resuscitation, reassessed frequently.
- Oxygen if hypoxic or in respiratory distress.
- Continuous/very frequent monitoring of vitals, urine output, Hct, glucose, electrolytes, renal and liver function.
- Blood transfusion when clinically significant bleeding is suspected or confirmed, particularly if shock persists with a falling Hct.
- Management of organ dysfunction and correction of glucose/electrolyte/metabolic abnormalities.
The NCVBDC page summarizes severe-dengue priorities as replacement of plasma losses, correction of electrolyte/metabolic problems, and blood transfusion when indicated. See the official NCVBDC management summary.
6. Platelet count: what it means and does not mean
Important interpretations
- A low platelet count is common in dengue.
- The trend and the patient’s condition matter more than one isolated result.
- Platelets often keep falling for a period even when the person has started improving.
- A platelet rise is reassuring, but it is not the only discharge criterion.
Platelet transfusion
Do not give platelets routinely just because the platelet count is low. Platelet transfusion is generally considered when there is significant active bleeding, bleeding with severe thrombocytopenia, a high-risk invasive procedure, or clinician-assessed coagulopathy. Giving prophylactic platelets without bleeding can cause fluid overload and transfusion complications without clear benefit.
Recent evidence does not replace the Indian clinical pathway. A 2025 systematic review on dengue diagnosis and management is Yang et al., PMID 41037858; management should still follow local clinical assessment and the NCVBDC algorithm.
7. Safe discharge checks
Discharge should generally wait until there is:
- No fever for at least 24-48 hours without antipyretics
- Improving appetite and general condition
- Stable circulation and good urine output
- No breathing difficulty from fluid accumulation
- No significant bleeding
- Stable Hct without IV fluids
- Platelet trend showing recovery or clear clinical stability, as judged by the treating team
- At least 48 hours after recovery from shock in severe cases
If you share the patient’s day of fever, symptoms, BP/pulse, urine output, platelet trend, Hct/Hb, WBC, creatinine, AST/ALT, and whether there is vomiting or bleeding, I can explain the pattern and which findings are most urgent.
This is a shared conversation. Sign in to Orris to start your own chat.